Sprint Nextel Corporation (NYSE:S) shares closed at $7.33, Boston Scientific Corporation (NYSE:BSX)

Posted by George Brook May 27, 2013 0 Comment 1253 views


Sprint Nextel Corporation (NYSE:S): In Friday’s trading session, Sprint Nextel Corporation (NYSE:S) gained 1.76%. Its opening price of $7.31 rose to touch an intraday high of $7.38 which eventually headed down to close at $7.30 per share. Over 19.60 million shares exchanged hands in the last trading session. This number stood below the average volume of 71.64 million that was measured over a 30-day period.

At the end of March, Sprint Nextel Corporation (NYSE:S) featured in the portfolio of 51 hedge funds. In recent months Sprint has seen reduced activity from some of the largest hedge funds in the world. Today, there are several indicators that can be used by investors to make sound choices about their investments and also monitor the holdings that they already have. Following insider trading activity and under-the-radar hedge funds are a great way to keep a tab on your investments. Sprint is a holding company and its operations are conducted largely by its subsidiaries. It operates in two different segments: Wireline and wireless and offers a range of communications services and products.

Boston Scientific Corporation (NYSE:BSX): In Friday’s trading session, Boston Scientific Corporation (NYSE:BSX) dipped 0.87%. Its opening price of $9.08 rose to touch an intraday high of $9.17 which eventually headed down to close at $9.04 per share. Over 18.91 million shares exchanged hands in the last trading session. This number stood below the average volume of 20.35 million that was measured over a 30-day period.

BSX is a company that develops, manufactures and markets medical devices. These are used in a variety of global medical specialties. In the year that ended 31 December 2011, the company products were sold via 7 core businesses: CRM, Endoscopy, Interventional Cardiology, Urology/Women’s Health, Peripheral Interventions, Neuromodulation, and Electrophysiology. In 2011 January 2011, Boston Scientific Corporation (NYSE:BSX) closed the acquisition of Intelect Medical, Inc. In the same period it also closed the acquisition of Sadra Medical, Inc. In 2011 March 2011, BSX completed the Atritech, Inc. acquisition. In 2011 February, it announced the ReVascular Therapeutics, Inc. and S.I. Therapies acquisitions. In 2011 January 2011, Boston Scientific Corporation (NYSE:BSX) sold the Neurovascular business to Stryker Corporation.


About George Brook

George Brook covers money and politics for GDP Insider. George is a veteran journalist who has also covered Congress, national political conventions and presidential politics. George also covers the White House as well as economic and domestic policy for GDP insider. George's reporting has won numerous awards, including two Scripps Howard awards, two National Headliners, two Gerald Loeb Awards, as well as honors from Sigma Delta Chi and the National Press Club.

View all post by George Brook Visit author's website

Write Your Comment